Company: ATIIU
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001437749-25-002910
Chunk: 131

Company: Archimedes Tech SPAC Partners II Co.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 131
---
 offer rules, our sponsor, initial shareholders, directors, executive officers, advisors or their affiliates may purchase shares or public warrants in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See “Proposed Business—Permitted Purchases of Our Securities.”

<div align='center'>83

CAPITALIZATION</div>

The following table sets forth our capitalization at September 30, 2024, and as adjusted to give effect to the filing of our amended and restated memorandum and articles of association, the sale of our 20,000,000 units in this offering for $200,000,000 (or $10.00 per unit) and the sale of 765,000 private units for $7,650,000 (or $10.00 per unit) and the application of the estimated net proceeds derived from the sale of such securities, assuming no exercise by the underwriters of their over-allotment option:

|                                                                                                                                                                                                                                                     |     | September 30, 2024 |         |   |     |             |             |   |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-------------------|--------:|:--|:----|:------------|------------:|:--|
|                                                                                                                                                                                                                                                     |     | Actual             |         |   |     | As Adjusted |             |   |
| Promissory note to sponsor(1)                                                                                                                                                                                                                       |     | $                  | 143,820 |   |     |             |           — |   |
| Deferred underwriting commissions                                                                                                                                                                                                                   |     |                    |       — |   |     |             |   7,000,000 |   |
| Over-allotment liability                                                                                                                                                                                                                            |     |                    |       — |   |     |             |     522,800 |   |
| Ordinary shares, subject to redemption; 0 shares actual and 20,000,000 shares as adjusted(3)                                                                                                                                                        |     |                    |       — |   |     |             | 201,000,000 |   |
| Shareholders’ deficit                                                                                                                                                                                                                               |     |                    |         |   |     |             |             |   |
| Preferred shares, $0.000